SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-018272
Filing Date
2024-01-29
Accepted
2024-01-29 17:08:05
Documents
16
Period of Report
2024-01-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d653684d8k.htm   iXBRL 8-K 26563
2 EX-10.1 d653684dex101.htm EX-10.1 15072
3 EX-10.2 d653684dex102.htm EX-10.2 21020
  Complete submission text file 0001193125-24-018272.txt   201604

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20240123.xsd EX-101.SCH 2499
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20240123_lab.xml EX-101.LAB 18699
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20240123_pre.xml EX-101.PRE 11676
18 EXTRACTED XBRL INSTANCE DOCUMENT d653684d8k_htm.xml XML 3917
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 24574563
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)